论文部分内容阅读
目的探究米非司酮联合米索前列醇治疗瘢痕子宫早孕流产中的临床效果。方法随机选择120例瘢痕子宫早孕流产女性,将其平均分成观察组与对照组(各60例)。对照组进行人工流产手术,观察组在对照组基础上联合使用米非司酮、米索前列醇两种药物。结果对照组患者的总有效率为78.33%,显著低于观察组的96.67%;对照组的不良反应发生率为18.33%,显著高于观察组的5.00%,组间差异均具有统计学意义(P<0.05)。结论采用米非司酮联合米索前列醇治疗瘢痕子宫早孕流产具有良好的临床疗效,且患者术后不良反应的发生情况显著减少。
Objective To investigate the clinical efficacy of mifepristone combined with misoprostol in the treatment of abortion due to uterine scar in early pregnancy. Methods A total of 120 women with aborted uterine early pregnancy during pregnancy were randomly divided into observation group and control group (60 cases each). The control group was treated with abortion. The observation group was treated with mifepristone and misoprostol on the basis of the control group. Results The total effective rate of the control group was 78.33%, which was significantly lower than that of the observation group (96.67%). The incidence of adverse reactions in the control group was 18.33%, which was significantly higher than that of the observation group (5.00%). The differences between the two groups were statistically significant P <0.05). Conclusion Mifepristone combined with misoprostol in the treatment of uterine scar pregnancy has a good clinical efficacy, and the incidence of postoperative adverse reactions was significantly reduced.